Yellow fever: an update

TP Monath - The Lancet infectious diseases, 2001 - thelancet.com
Yellow fever, the original viral haemorrhagic fever, was one of the most feared lethal
diseases before the development of an effective vaccine. Today the disease still affects as …

Tick-borne encephalitis

TS Gritsun, VA Lashkevich, EA Gould - Antiviral research, 2003 - Elsevier
Tick-borne encephalitis (TBE) is one of the most dangerous human infections occurring in
Europe and many parts of Asia. The etiological agent Tick-borne encephalitis virus (TBEV) …

Japanese encephalitis: the virus and vaccines

SI Yun, YM Lee - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
Japanese encephalitis (JE) is an infectious disease of the central nervous system caused by
Japanese encephalitis virus (JEV), a zoonotic mosquito-borne flavivirus. JEV is prevalent in …

[HTML][HTML] Japanese encephalitis—a pathological and clinical perspective

D Ghosh, A Basu - PLoS neglected tropical diseases, 2009 - journals.plos.org
Japanese encephalitis (JE) is the leading form of viral encephalitis in Asia. It is caused by
the JE virus (JEV), which belongs to the family Flaviviridae. JEV is endemic to many parts of …

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease

NR Hegde, MM Gore - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Japanese encephalitis (JE) is a serious public health concern in most of Asia. The disease is
caused by JE virus (JEV), a flavivirus transmitted by Culex mosquitoes. Several vaccines …

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

B Guy, F Guirakhoo, V Barban, S Higgs, TP Monath… - Vaccine, 2010 - Elsevier
Dengue viruses (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV) are
major global health and growing medical problems. While a live-attenuated vaccine exists …

Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates

F Guirakhoo, K Pugachev, Z Zhang, G Myers… - Journal of …, 2004 - Am Soc Microbiol
To construct chimeric YF/DEN viruses (ChimeriVax-DEN), the premembrane (prM) and
envelope (E) genes of yellow fever (YF) 17D virus were replaced with those of each wild …

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

F Guirakhoo, J Arroyo, KV Pugachev, C Miller… - Journal of …, 2001 - Am Soc Microbiol
We previously reported construction of a chimeric yellow fever-dengue type 2 virus
(YF/DEN2) and determined its safety and protective efficacy in rhesus monkeys (F …

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

F Guirakhoo, R Weltzin, TJ Chambers… - Journal of …, 2000 - Am Soc Microbiol
ABSTRACT A chimeric yellow fever (YF)-dengue type 2 (dengue-2) virus (ChimeriVax-D2)
was constructed using a recombinant cDNA infectious clone of a YF vaccine strain (YF 17D) …

Origins, evolution, and vector/host coadaptations within the genus Flavivirus.

EA Gould, X de Lamballerie, PM Zanotto… - Advances in virus …, 2003 - europepmc.org
Although viruses in the genus Flavivirus share complex antigenic interrelationships, they
can be divided into four phylogenetic/ecological groups: two mosquito-borne groups, a tick …